How is pharmaceutical grade gelatin manufactured?

Beyond Biopharma · Pharmaceutical Gelatin FAQ

Short answer: Pharmaceutical grade gelatin is manufactured from traceable animal hide, skin or bone by first preparing the collagen with an acid or alkali step, then extracting it with a series of hot-water runs (known as cuts), purifying the resulting liquor through filtration and ion exchange, concentrating and sterilising it, cooling it to set a gel, drying the gel to a low residual moisture, milling it to powder, blending lots to a target specification and testing each batch before release. The overall route mirrors food-grade gelatin, but for pharmaceutical use every step is run under much stricter purity, microbial, heavy-metal and process controls, and each lot is documented and released against a finished specification.

The general process sequence

Pharmaceutical grade gelatin comes from the same collagen chemistry as any gelatin, but the manufacturing line is engineered and documented for pharmaceutical-use expectations. A typical route runs through the following stages:

1. Raw-material preparation. Traceable hide, skin or bone is cleaned, sized and pre-treated with dilute acid (an acid process, giving Type A gelatin) or soaked in lime/alkali (an alkali process, giving Type B gelatin) to loosen and prepare the collagen.
2. Hot-water extraction (the cuts). The prepared material is extracted repeatedly with hot water. Each successive extraction run — a “cut” — yields gelatin of different quality, typically changing in gel strength and viscosity.
3. Clarification and purification. The dilute liquor from each cut is filtered to remove solids and fat, then passed over ion-exchange resins to take out salts and other ions.
4. Concentration. The cleaned liquor is concentrated, commonly under vacuum evaporation, before any sterilisation.
5. Sterilisation. The concentrate is sterilised by heat (for example UHT or an equivalent validated heat treatment) and then fine-filtered to control microbiology.
6. Gel cooling. The hot, purified solution is chilled to set a firm gel so it can be dried in a controllable form.
7. Drying. The gel is dried to a low residual moisture — typically around 10–13 % — under controlled air flow.
8. Milling and blending. The dried sheets or noodles are milled to powder and, where needed, different cuts are blended to bring a lot to a target specification.
9. Batch release. Each lot is sampled and tested against the written specification through batch QC before release on a certificate of analysis (COA).

Why pharmaceutical manufacturing is stricter

The sequence above is recognisable from food-gelatin production, so it helps to say clearly what changes. More exacting raw-material selection and traceability, validated cleaning and sterilisation, tighter in-process control of every unit operation, documented water quality, and a heavier analytical burden all raise the output high enough to be used in a medicine. Where a food plant may tolerate a wider spread across runs, the pharma line is run so each lot reproduces the previous one within a tight spec, because the gelatin becomes part of a regulated dose form or medical material.

Key parameters that are controlled

Typical ranges are given for orientation only; every value on a delivery should be read from the supplier’s COA for the specific lot, and the applicable pharmacopoeia or product requirement defines the actual limits.

How manufacturing links to other questions

The cutting, purifying and sterilising stages connect directly to two other common questions. To understand what happens in the extraction runs and how the separate cuts begin to differ, see how the manufacturing route produces varied gelatin. To learn how the liquor is taken from a crude extract up to a pharma-clean product after extraction, see how gelatin is purified to pharmaceutical standards. Both are covered elsewhere in this pharmaceutical gelatin FAQ.